Kazia Executes Agreement To Commence GBM Agile Pivotal Study
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SYDNEY, Oct. 16, 2020 /PRNewswire-AsiaNet/-- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has executed a definitive agreement with the Global Coalition for Adaptive Research (GCAR) to commence Kazia'...
Authors: LATEST ASIANET NEWS RELEASES